GLEAM PHARMACEUTICALS PRIVATE LIMITED
GLEAM PHARMACEUTICALS PRIVATE LIMITED is a WEST BENGAL based PRIVATE LIMITED company, Registered at dated 15-FEB-2001 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of GLEAM PHARMACEUTICALS PRIVATE LIMITED is U27101WB2001PTC092902 and registration number is 092902.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies KOLKATA India. Authorized share capital of GLEAM PHARMACEUTICALS PRIVATE LIMITED is Rs. 2000000 and its paid up capital is Rs. 2000000. It aspire to serve in METALS, CHEMICALS AND PRODUCTS THEREOF MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
GLEAM PHARMACEUTICALS PRIVATE LIMITED has 2 directors PRIYA RANJAN PALBAG, GOPA BHATTACHARYYA,
The registered Email address of GLEAM PHARMACEUTICALS PRIVATE LIMITED is cdas@vsnl.net and its registered address is 246D, A. P. C. ROAD FLAT-1D KOLKATA KOLKATA WB 700006 IN WEST BENGAL WEST BENGAL india 700006.
The current status of GLEAM PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
GLEAM PHARMACEUTICALS PRIVATE LIMITED
KOLKATA
ACTIVE
METALS, CHEMICALS AND PRODUCTS THEREOF MANUFACTURING
U27101WB2001PTC092902
15-FEB-2001
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
2000000
2000000
CONTACT DETAILS
700006
INDIA
246D, A. P. C. ROAD FLAT-1D KOLKATA KOLKATA WB 700006 IN
cdas@vsnl.net
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
01105535 | PRIYA RANJAN PALBAG | Director | 15/02/2001 |
01105601 | GOPA BHATTACHARYYA | Director | 15/02/2001 |
Details Updated by Companies
Quick Links
- All Registered company of WEST BENGAL
- Company Registered in WEST BENGAL
- All Registered company of KOLKATA in WEST BENGAL
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.